STERIS (STE) Stock Forecast & Price Target
$22.50B
Market Cap
27.90
P/E
20.58
Forward P/E
56
Score
STE price $230.75 +1.97 +0.86%
Stocklytics score rationale: value 44, quality 65, growth 58.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 2612756000 | 2619996000 | 2782170000 | 3030895000 | 3107519000 | 4223403000 | 4536266000 | 5138701000 | 5459515000 | 5935900000 |
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It…
Consensus Buy from 10 analysts. Average price target $271.33, +17.6% versus the current price. Low $269.00. High $275.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $271.33 for STERIS (STE), 17.7% above the current price of $230.53. Of 10 analysts covering the stock, 7 rate it Buy or Strong Buy, 3 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $269.00 |
|---|---|
| Average | $271.33 |
| High | $275.00 |
The average is 17.7% above the current price of $230.53.
Of 10 analysts, 7 rate STERIS Buy or Strong Buy, 3 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $10.20, revenue $5.94 billion. 2027, EPS $11.21, revenue $6.38 billion.
The Stocklytics Score for STE is 56 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$271.33 average, with a published range of $269.00 to $275.00.
The consensus is Buy from 10 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $10.20. The average revenue estimate is $5.94 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: STERIS · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$22.50B
Market Cap
27.90
P/E
20.58
Forward P/E
56
Score